Fetal rat src mRNA levels were much higher in the central nervous system than any peripheral organ.

However, methods to efficiently select patients responsive to Src inhibitors are lacking.

This was one of the key points made in the SRC proposals.

Recent data demonstrate strong associations between anti-RNA polymerase III antibodies and SRC.

Further studies to explore potential therapeutic strategies, including Src inhibitors, are ongoing.